## KVUE: Kenvue Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -1.2% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($16.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. KVUE SEC Filings - Kenvue Inc. 10-K, 10-Q, 8-K Forms**
- Source: Stock Titan | 20251227T140846 | Neutral | Relevance: 100%
- This page provides a comprehensive resource for Kenvue (KVUE) SEC filings, including annual 10-K reports, quarterly 10-Q filings, 8-K material events, and insider trading Form 4s. Stock Titan uses AI to summarize these dense documents, offering insights into royalty agreements, product liability reserves, and supply chain impacts, and covers executive compensation and insider transactions.

**2. DAVENPORT & Co LLC Sells 186,412 Shares of Kenvue Inc. $KVUE**
- Source: MarketBeat | 20251227T090808 | Neutral | Relevance: 100%
- DAVENPORT & Co LLC significantly reduced its stake in Kenvue Inc. by selling 186,412 shares, leaving them with 205,607 shares valued at $3.349 million. This transaction occurred in the third quarter, alongside other institutional investors adjusting their holdings. Despite this, a director, Jeffrey C. Smith, increased his ownership substantially by purchasing 3.2 million shares.

**3. Kenvue Stock (NYSE: KVUE) News Today: Kimberly-Clark Deal Update, Insider Buying, Analyst Forecasts â€” December 25, 2025**
- Source: ts2.tech | 20251225T162955 | Somewhat-Bullish | Relevance: 100%
- This article provides an update on Kenvue Inc. (NYSE: KVUE) stock on December 25, 2025, focusing on its acquisition by Kimberly-Clark. It details the deal's financial terms, timeline, and the reasons behind the current market spread, alongside key catalysts to watch as the deal progresses. The article also highlights recent insider buying by Starboard's Jeffrey C. Smith, Kenvue's latest quarterly fundamentals, legal challenges regarding its dividend with a focus on Tylenol-related litigation, and analyst forecasts.

**4. Kenvue Insider Buying and the Kimberly-Clark Megamerger: A Value Investor's Deep Dive**
- Source: FinancialContent | 20251225T115400 | Bullish | Relevance: 100%
- The acquisition of Kenvue by Kimberly-Clark for $48.7 billion is transforming the consumer staples sector, creating a new global leader in consumer health. Activist investor Jeffrey Smith's significant post-announcement purchases of Kenvue shares signal a strong belief in the combined entity's long-term value, despite initial market skepticism and concerns about legal liabilities. This megamerger highlights a strategic shift towards high-margin wellness categories and the potential for exploiting "litigation discounts" in valuations.

**5. Kenvue Inc. stock rises Wednesday, outperforms market**
- Source: MarketWatch | 20251224T165800 | Bullish | Relevance: 100%
- Kenvue Inc. (KVUE) shares rose 1.12% to $17.21 on Wednesday, outperforming the broader market. This marked the stock's second consecutive day of gains, as the S&P 500 Index and Dow Jones Industrial Average also saw increases.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (+0.0%)
- Blackrock Inc.: 7.6% (-1.9%)
- Price (T.Rowe) Assoc: 6.0% (-31.5%)
- State Street Corpora: 6.0% (-0.2%)
- FMR, LLC: 4.7% (-9.3%)

### Key Risks

1. Long-term trend broken: trading 14.3% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.88 indicates undervaluation relative to growth. Forward P/E 15.6x stretched relative to 7% growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.9B |
| Beta | 0.56 |
| 52W Range | $14.02 - $25.17 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.88 |
| Forward P/E | 15.6 |
| Current P/E | 16.7 |
| YoY Growth | 7.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -1.2% (minimal 5-day change). Below STRENGTH zone by 4.2pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Below SMA200 (0.86x), long-term trend not supportive. RSI neutral at 57. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.18% (CS: 41) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | -0.04 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.053x | Above |
| vs SMA200 | 0.857x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $17.21
- **Stop Loss:** $16.57 (3.7% risk)
- **Target:** $17.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 859
- **Position Value:** $14,783.39
- **Portfolio %:** 14.78%
- **Risk Dollars:** $550.00
- **Risk Per Trade:** 0.55%
- **Modifiers:** L1 110% | L2 50% | Combined 0.55x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-05 (Est: $0.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.26 | $0.28 | +5.7% |
| 2025Q2 | $0.28 | $0.29 | +2.2% |
| 2025Q1 | $0.23 | $0.24 | +5.4% |
| 2024Q4 | $0.26 | $0.26 | +1.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*